{"nct_id":"NCT04276233","title":"Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2021-06-29","start_date_type":"ACTUAL","primary_completion_date":"2023-10-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-28","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}